While this study was focused on cells derived from breast cancer and glioblastoma, eHsp90 has also been found for other cancer cells including prostate and melanoma so it is possible that impermeant Hsp90 inhibitors may also have application to reduce invasion for these cancers. This evidence concerns the gene HSP90AA1 and breast cancer.